Symbols / GNFT
GNFT Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-04-02 17:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- These Analysts Just Made An Downgrade To Their Genfit S.A. (EPA:GNFT) EPS Forecasts - simplywall.st ue, 23 Sep 2025 07
- GENFIT announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market - GlobeNewswire hu, 20 Nov 2025 08
- Genfit: Iqirvo's Success Can't Outweigh ACLF Pipeline Risks (NASDAQ:GNFT) - Seeking Alpha Mon, 12 May 2025 07
- Leerink Partners Maintains Genfit(GNFT.US) With Buy Rating, Announces Target Price $8 - 富途牛牛 ue, 23 Sep 2025 07
- Genfit-Ipsen’s elafibranor hits endpoint in phase III for PBC - BioWorld MedTech Fri, 30 Jun 2023 07
- Genfit Balances Ipsen Partnership With High-Risk Pipeline Ambitions (NASDAQ:GNFT) - Seeking Alpha hu, 21 Nov 2024 08
- Why DMAAU stock is trending among retail traders - July 2025 Setups & Growth Oriented Trading Recommendations - mfd.ru Sun, 15 Feb 2026 02
- Celloram nabs $176M deal with Genfit for inflammasome inhibitor - BioWorld MedTech ue, 01 Aug 2023 07
- Can Critical Mineral Resources PLC (98J) stock stage a strong rebound this quarter - July 2025 Outlook & AI Forecasted Stock Moves - mfd.ru ue, 10 Feb 2026 11
- Why Transurban Group Debt Equity Composite Units (TU9) stock benefits from AI revolution - 2025 Historical Comparison & Free Fast Entry Momentum Trade Alerts - mfd.ru Fri, 20 Feb 2026 16
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for GNFT
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|